PlainRecalls

Lin-Zhi International Inc

Compiled from official public sources by the publisher.

5 recalls on record · Latest: May 8, 2019

Subscribe to new Lin-Zhi International Inc recalls (RSS)

Agency notice ledger

Federal filing book Lin-Zhi International Inc LIGHT-BOOK · SINGLE-AGENCY

#2,537 of 14,151 · 5 notices · 0.005% archive

  • BOOK 5 notices
  • RANK #2,537 of 14,151
  • SHARE 0.005% archive
  • AGENCY FDA Devices (5)
  • CAT medical devices
  • CATS 1 category
  • LATEST May 8, 2019
  • PHOTO A G Specialty Foods I…

Nearest notice-volume peer: A G Specialty Foods Inc (0 notice gap)

Lin-Zhi International Inc accounts for about 0.005% of the 104,423-notice archive on 5 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Lin-Zhi International Inc's standing among 14,151 recalling firms

Lin-Zhi International Inc ranks 2,537th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Lin-Zhi International Inc vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

5 2537th of 14151 higher than 11,411 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Lin-Zhi International Inc in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Lin-Zhi International Inc holds about 0.005% of archive notices alongside 5 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Devices Low May 8, 2019

Ethyl Alcohol Enzymatic Assay, (a) REF 0220 (small test kit), (b) REF 0221 (large test kit) Product Usage: Detergent causes faster degradation in EtOH assay. Possible container or pitchers with some detergent residue was used while producing R2 of the defective lot.
FDA Devices Low Apr 2, 2014

Single Analyte DAU Calibrator (5 mL) Norbuprenorphine: Cutoff Calibrator; IVD - for in vitro diagnostic use only; Lin-Zhi International Sunnyvale, CA The Norbuprenorphine Drug of Abuse (DAU) cutoff Calibrator is used for qualitative and semi-qualitative calibration of the Lin-Zhi Internal, Inc. Buprenorphine (BUP) enzyme Immunoassay (REF # A53684) on the Synchron Clinical Analyzer
FDA Devices Moderate Mar 19, 2014

Cannabinoids DAU Calibrator Control Level 1 (62.5 ng/mL) This solution is prepared from non-sterile urine and should be handled as potentially infectious. IVD; The Cannabinoids (cTHC also known as THC version c) DAU negative and positive controls are human urine-based liquids and ready to use. The constituent is a processed drug-free human urine matrix, containing buffers, stabilizers, and less than 0.09 % of sodium azide. The controls are prepared by spiking known concentrations of 11-no
FDA Devices Moderate Mar 19, 2014

Cannabinoids DAU Calibrator Control Level 1 (37.5 ng/mL) This solution is prepared from non-sterile urine and should be handled as potentially infectious. IVD; The Cannabinoids (cTHC also known as THC version c) DAU negative and positive controls are human urine-based liquids and ready to use. The constituent is a processed drug-free human urine matrix, containing buffers, stabilizers, and less than 0.09 % of sodium azide. The controls are prepared by spiking known concentrations of 11-no
FDA Devices Low Dec 4, 2013

Single Analyte Urine DAU Control (5 m L Norbuprenorphine, Level II control For In Vitro Diagnostic Use Only. store at 2 - 8 degrees C. Contents: Contains 13 mg/Ml of Norbuprenorphine in human urine with sodium azide as a preservative. Manufacturer: Lin-Zhi International, Inc. 670 Almanor Ave. Sunnyvale, CA 94085 The Norbuprenorphine Drug of Abuse (DUB) Positive control is used as assayed quality control material to monitor the precision of the Lin-Zhi International, Inc. Buprenorphin

Lin-Zhi International Inc is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name Lin-Zhi International Inc? ▼
PlainRecalls indexes 5 distinct federal recall events naming Lin-Zhi International Inc, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Lin-Zhi International Inc sit among other recalling firms? ▼
Lin-Zhi International Inc ranks #2,537 of 14,151 by distinct recall-event count among 14,151 firms in this archive (81st percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Lin-Zhi International Inc's notices? ▼
FDA Devices accounts for 5 of this firm's 5 indexed notices.
What product category dominates Lin-Zhi International Inc's filing book? ▼
Filings for Lin-Zhi International Inc span 1 product category, led by medical devices. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Lin-Zhi International Inc: 5 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Devices). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Lin-Zhi International Inc; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026